CONCENTRATION	9 Months Ended
Apr. 30, 2023
CONCENTRATION
CONCENTRATION	NOTE 6 – CONCENTRATION Revenue During the year ended July 31, 2022, the Company entered into a consulting agreement in the field of healthcare for a monthly fee of $8,333 with First DP Ventures, LP. The services were performed by a member of the Company’s board of directors pursuant to an Employment Contract. As of April 30, 2023, all revenue of $75,001 and accounts receivable of $8,333 were diverted from one customer. Cost of revenue During the nine months ended April 30, 2023, the cost of revenue of $71,771 was for the payroll expenses related to a member of the Company’s board of directors, who performed the consulting services.

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-URI https://asc.fasb.org/topic&trid=2134479

Name:	us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration